Clinical Trial Update: Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) [NA]

View source ↗

Summary

Clinical trial WARFARIN investigates pharmacogenetic testing at warfarin initiation to reduce adverse events in adults. The study status is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Mitral Valve Disease
• Pulmonary Embolism

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Iverson Genetic Diagnostics, Inc. | Conditions: Anti-coagulation Therapy, DVT | NA | Status: SUSPENDED